Assertio Therapeutics, Inc. buy PlusUltra
Start price
13.03.20
/
50%
€0.71
Target price
22.05.20
€3.00
Performance (%)
2.13%
End price
22.05.20
-
Summary
This prediction ended on 22.05.20 with a price of -. With a performance of 2.13%, the BUY prediction by PlusUltra for Assertio Therapeutics, Inc. closed with a slight gain. PlusUltra has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Assertio Therapeutics, Inc. | -2.667% | -2.667% | -87.813% | -92.074% |
| iShares Core DAX® | 3.153% | 1.504% | 9.129% | 62.821% |
| iShares Nasdaq 100 | 7.431% | -1.584% | 28.642% | 85.805% |
| iShares Nikkei 225® | 8.571% | -4.324% | 53.026% | 77.327% |
| iShares S&P 500 | 4.578% | 1.920% | 23.965% | 69.680% |
Comments by PlusUltra for this prediction
In the thread Discuss Assertio Therapeutics, Inc.
Buy with target price 3.0